Skip to content

Home
About Us
- Board of Directors
- Management Team
Technology
News/Resources
Investor Centre
Contacts

ASX Announcements 2013

5 Dec 2013
Presentation of HIV Data at International HIV Persistence Meeting
27 Nov 2013
Independent Research Validates Biotron HCV Drug Candidate
21 Nov 2013
Ethics Approval for New HCV Three Month Dosing Study
8 Nov 2013
Director Change
8 Nov 2013
Results of Annual General Meeting
8 Nov 2013
Presentation to Annual General Meeting
6 Nov 2013
Biotron Details Headline Trial Data at International Liver Conference
28 Oct 2013
Biotron to Present at Australia Biotech Invest 2013
25 Oct 2013
BIT225 Enhances Anti-viral Activity In HIV/HCV Genotype 3 Co-infected Patients; Phase 2 Data To Be Presented At Leading International Liver Meeting
21 Oct 2013
Quarterly Report 30 September 2013
10 Oct 2013
Annual Report for year ended 30 June 2013 and Notice of Annual General Meeting
28 Aug 2013
Year End Accounts and Preliminary Final Report Year Ending 30 June 2013
16 Aug 2013
August 2013 edition of BITNews
14 Aug 2013
BIT225 Capsule Formulation Trial Completed
31 Jul 2013
Patient Enrolment In Phase 2 BIT225 Co-infected Study Completed
26 Jul 2013
Quarterly Report 30 June 2013
1 Jul 2013
Presentation of HIV Trial Data at International AIDS Society Conference
5 Jun 2013
Biotron to Present at Asia Biotech Invest 2013 – Hong Kong
31 May 2013
R&D Tax Incentive
30 May 2013
Presentation of HIV Data at International AIDS Society Conference
1 May 2013
Poster presented at European Liver Conference
1 May 2013
Presentation at European Liver Conference
30 Apr 2013
Quarterly Report 31 March 2013
26 Apr 2013
CEO presentation at the 2013 Bio International Convention
10 Apr 2013
April 2013 edition of BITNews
19 Mar 2013
HIV trial validates novel drug mechanism
28 Feb 2013
Half-year report 31 December 2012
17 Jan 2013
Quarterly Report 31 December 2012

<<
2024

2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
>>

Investor Centre

Investor Centre

© Biotron Limited 2016 ABN 60 086 399 144 Site updated 6 September 2024 Legal Notices and Privacy